{"disease":{"id":"non-alcoholic-fatty-liver-disease-nafld-non-alcoholic-steatohepatitis-nash","name":"non alcoholic fatty liver disease nafld non alcoholic steatohepatitis nash"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03151473","title":"Longitudinal Observational Study Of Chinese With NAFLD/NASH","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Humanity and Health Research Centre","has_results":false},{"nct_id":"NCT07180745","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Badr University","has_results":false},{"nct_id":"NCT04682600","title":"The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF","phase":"NA","overall_status":"UNKNOWN","enrollment_count":164,"lead_sponsor_name":"Sonic Incytes","has_results":false},{"nct_id":"NCT05384652","title":"Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT02754037","title":"Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03572465","title":"Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis","phase":"","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT04165343","title":"Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT04019561","title":"A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"MedImmune LLC","has_results":true},{"nct_id":"NCT02196831","title":"Tesamorelin Effects on Liver Fat and Histology in HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT05560607","title":"Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06024408","title":"A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}